Trial Now Recruiting: BEhavioral and Adherence Model for Improving Quality, Health Outcomes and Cost-Effectiveness of healthcaRe (NCT06856902)
WHY IT MATTERS
This trial directly addresses medication non-adherence across multiple rare disease categories, meaning patients with rare conditions could benefit from proven strategies to better manage their treatments and health outcomes.
Researchers are looking for 3,100 people to join a study about why patients don't take their medications as prescribed. The study will test a new approach to help people stick to their treatment plans, which could improve their health and reduce unnecessary hospital visits. About half of all patients don't take their medicines the right way, and this problem gets worse when treatment also requires lifestyle changes.
NCT ID: NCT06856902 Status: RECRUITING Conditions: Cardiovascular Diseases, Endocrinology, Inmunology, Neurology, Oncology, Rare Diseases Phase: NA Enrollment: 3100 Sponsor: Technical University of Madrid Summary: Lack of adherence to treatment is a widespread issue worldwide, which leads to higher healthcare utilisation rates and even premature death. While the level of adherence may differ based on the specific condition and treatment, studies estimate that approximately 50% of medications are not taken according to the prescribed instructions. In addition, adherence rates tend to decrease even further when the treatment requires a behavioural change. Literature reviews about factors that affect people'
YOU CAN ACT ON THIS
If you have a rare disease and struggle with taking medications as prescribed, check if you meet eligibility criteria and contact the study team at clinicaltrials.gov using NCT06856902 to learn how to enroll.